What is EBE Product Accreditation and how does it work?
What is EBE Product Accreditation?
EBE Product Accreditation requires an application from a product owner. This application includes
a. clinical trials on their specific product (Efficacy assessment) and
b. data on the reproducibility of their product (Quality & Equivalence assessment).
The data reviewed includes published research, regulatory approvals and independent certifications of their product.
Our team of specialists from around the world have created the process, which has been shared in international conferences and is fully transparent.
See below in “What exactly is used for EBE’s specific evidence assessment?”
How is the assessment independent?
The product accreditation is overseen by the Expert Advisory Board of EBE.
Chair: Professor John Funder – endocrinologist, former chair of the ad board of Australian NICM natural health institute – the biggest research/policy institute in Australia in the sector.
Member: Professor Theo Dingermann Goethe University Frankfurt – a pharmaceutical biology expert and father of the movement to communicate that scientific evidence for natural health products is product specific.
Member: Professor Michael Habs Ludwig Maximilian University of Munich – a medical doctor with an extensive experience in the pharmaceutical industry, particularly specific evidence natural medicines, now teaching toxicology and phytopharmacology in the department of medicine at the Ludwig Maximilian University.
The Expert Advisory Board appoint independent assessors of the products, with skills and experience relevant to the particular product. These assessors are required to have not worked with the product or its competitors for at least 3 years. To avoid influence from applicants, the identity of assessors remains confidential.
What exactly is used for EBE’s specific evidence assessments?
Below are the links to these 2 assessments.
Quality & Equivalence assessment:
What happens following assessment?
After product assessments are complete, unsuccessful products are provided insights on why their product failed to meet the EBE standards. It is the goal of EBE to increase the number of products that have specific clinical evidence and that are made reproducibly.
Successful products are offered the opportunity to license the EBE accreditation mark which allows them to demonstrate that they have achieved the independent standards of EBE. This accreditation mark allows people to quickly find accredited products.